Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Analysts Say White House Promised Merck to "Do What Was Required" to Ax Public Option From Healthcare Reform
BNET Pharma
Tuesday, December 8, 2009 - 11:15am
tags:
Merck, healthcare reform
More from Genentech's McCracken on the Future of Pharmaceutical Sales
BNET Pharma
Tuesday, December 8, 2009 - 11:13am
tags:
pharmaceutical sales, Genentech, pharma industry
Feeling Neurotic? Then Take An Antidepressant
Pharmalot
Tuesday, December 8, 2009 - 11:11am
tags:
antidepressants, Paxil, GSK
Prospecting for Stocks: DepoMed
Motley Fool
Tuesday, December 8, 2009 - 11:10am
tags:
Depomed
Novartis' Cancer Plan
Forbes
Tuesday, December 8, 2009 - 11:09am
tags:
cancer, Novartis, Tasigna, Gleevac, Afinitor
Premature Ejaculation: Marketing the Condition Before the Drug
WSJ Online
Tuesday, December 8, 2009 - 11:07am
tags:
Sciele, premature ejaculation
Actelion latest casualty as Roche trims portfolio
Reuters
Tuesday, December 8, 2009 - 10:28am
tags:
Roche, Actelion, Genmab
AstraZeneca to cover copays for patients on its prescription savings plan starting Jan. 1
Yahoo/AP
Tuesday, December 8, 2009 - 10:26am
tags:
co-pays, AstraZeneca
Bristol-Myers enters research partnership with Tranzyme worth up to $16M over 2 years
Yahoo/AP
Tuesday, December 8, 2009 - 10:25am
tags:
Tranzyme, partnerships, Bristol-Myers Squibb
Buyout Buzz at ASH Hematology Confab
Seeking Alpha
Monday, December 7, 2009 - 7:43pm
tags:
M&A, Allos, Celgene, Cyclacel, Seattle Genetics
Biotechs to Watch in the Blood Business
Minyanville
Monday, December 7, 2009 - 5:50pm
tags:
ONYX Pharmaceuticals, Cephalon, Roche, Biogen Idec, Novartis, Incyte
Onyx Treatment Fights Cancer With Few Side Effects
Bloomberg
Monday, December 7, 2009 - 5:37pm
tags:
ONYX Pharmaceuticals, cancer, Multiple Myeloma
Zyprexa, Seroquel expanded to teenagers
Fierce Pharma
Monday, December 7, 2009 - 5:24pm
tags:
Seroquel, Zyprexa, Eli Lilly, antipsychotics
Biogen Idec Blinks: Is It Enough for Facet Biotech, or Will the Drama Continue?
BNET Pharma
Monday, December 7, 2009 - 12:48pm
tags:
Facet Biotech, Biogen Idec, M&A
Why AstraZeneca's $1B Antidepressant Bet Faces Big Risks
BNET Pharma
Monday, December 7, 2009 - 12:48pm
tags:
AstraZeneca, antidepressants, Seroquel, Targacept
Immunogen lifted by cancer-drug trial
Bizjournals.com
Monday, December 7, 2009 - 12:39pm
tags:
Immunogen, cancer, drug trials
Cubist halts trial enrollment over death-rate concerns
Bizjournals.com
Monday, December 7, 2009 - 12:35pm
tags:
Cubist Pharmaceuticals, drug trials
Celgene Buys Gloucester Pharma
TheStreet.com
Monday, December 7, 2009 - 12:34pm
tags:
Celgene, Glouchester Pharma, M&A
Somaxon Plunges on U.S. Rejection of Insomnia Drug
Bloomberg
Monday, December 7, 2009 - 12:33pm
tags:
insomnia, Silenor, Somaxon, FDA
Santarus on a Roll
Yahoo/Zacks.com
Monday, December 7, 2009 - 12:32pm
tags:
Santarus, Merck, GSK, Zegerid

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.